[1] Yuan A, Sonis S.Emerging Therapies for the Prevention and Treatment of Oral Mucositis[J]. Expert Opin Emerg Drugs, 2014, 19(3):343-351.DOI:10.1517/14728214.2014.946403.
[2] Kyte D G, Calvert M, Van Der Wees P J, et al. An Introduction to Patient-reported Outcome Measures (Proms) in Physiotherapy[J]. Physiotherapy, 2015, 101(2):119-125. DOI:10.1016/J.Physio.2014.11.003.
[3] Bingham C O, Noonan V K, Auger C, et al.Montreal Accord on Patient-reported Outcomes (Pros) Use Series-paper 4: Patient-reported Outcomes Can Inform Clinical Decision Making in Chronic Care[J]. J Clin Epidemiol, 2017, 89:136-141. DOI:10.1016/J.Jclinepi.2017.04.014.
[4] Evaluation T, Evaluation A, Devices A, et al. Guidance for Industry Patient-reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims[EB/OL]. [2018-08-22].Http://www.Fda.Gov/Drugs/Guidancecomplianceregulatory information/Guidances/Default.Htm.
[5] Department of Health(2009). Guidance on the Routine Collection of Patient Reported Outcome Measures(PROMs)[EB/OL].(2008-12-08)[2018-07-14].http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_092625.pdf
[6] 李娜. 比较电子化和传统纸质病人报告结局在神经科学临床研究中的应用[D]. 上海: 复旦大学, 2012.
[7] Coons S J, Gwaltney C J, Hays R D, et al.Recommendations on Evidence Needed to Support Measurement Equivalence Between Electronic and Paper-based Patient-reported Outcome (PRO) Measures: ISPOR Epro Good Research Practices Task Force Report[J].Value Health, 2009, 12(4):419-429. DOI:10.1111/J.1524-4733.2008.00470.X.
[8] Muehlhausen W, Doll H, Quadri N, et al.Equivalence of Electronic and Paper Administration of Patient-reported Outcome Measures: A Systematic Review and Meta-analysis of Studies Conducted between 2007 and 2013[J]. Health Qual Life Outcomes, 2015, 13:167. DOI:10.1186/S12955-015-0362-X.
[9] Dueck A C, Mendoza T R, Mitchell S A, et al.Validity and Reliability of the US National Cancer Institute’s Patient-reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)[J]. JAMA Oncol,2015, 1(8):1051-1059.DOI:10.1001/jamaoncol.2015.2639.
[10] Gunn G B,Atalar B,Mendoza T R,et al.Linguistic Validation of the Turkish Version of the M.D.Anderson Symptom Inventory-head and Neck Cancer Module[J].Balkan Med J, 2016,33(3):339-343.DOI:10.5152/Balkanmedj.2015.150148.
[11] Zeng L, Koo K, Zhang L, et al.Fatigue in Advanced Cancer Patients Attending an Outpatient Palliative Radiotherapy Clinic as Screened by the Edmonton Symptom Assessment System[J]. Support Care Cancer, 2012, 20(5):1037-1042. DOI:10.1007/S00520-011-1179-8.
[12] Watanabe S M, Nekolaichuk C L, Beaumont C.The Edmonton Symptom Assessment System, A Proposed Tool for Distress Screening in Cancer Patients: Development and Refinement[J]. Psychooncology, 2012, 21(9):977-985. DOI:10.1002/Pon.1996.
[13] Dong Y, Chen H, Zheng Y, et al. Psychometric Validation of the Edmonton Symptom Assessment System in Chinese Patients[J]. J Pain Symptom Manage, 2015, 50(5):712-717.e2. DOI:10.1016/J.Jpainsymman.2015.05.018.
[14] National Institutes of Health. Patient-reported Outcomes Measurement Information System - annoucements[EB/OL].[2019-04-30]. https://Commonfund.Nih.Gov/Promis/Index.
[15] Ringash J, Bernstein L J, Cella D, et al.Outcomes Toolbox for Head and Neck Cancer Research[J]. Head Neck, 2015, 37(3):425-439. DOI:10.1002/Hed.23561.
[16] Bjordal K, Ahlner-Elmqvist M, Tollesson E, et al.Development of a European Organization for Research and Treatment of Cancer (EORTC) Questionnaire Module to Be Used in Quality of Life Assessments in Head and Neck Cancer Patients. EORTC Quality of Life Study Group[J]. Acta Oncol,1994,33(8):879-885.DOI:10.3109/0284186940098450.
[17] 肖巍魏,韩非,赵充,等. 鼻咽癌患者生存质量FACT-H&N量表测评[J]. 中国公共卫生, 2010, 26(7):827-829. DOI:10.11847/Zgggws2010-26-07-13.
[18] Wyatt G, Pugh S L, Wong R K, et al.Xerostomia Health-Related Quality of Life: NRG Oncology RTOG 0537[J]. Qual Life Res,2016, 25(9):2323-2333.DOI:10.1007/S11136-016-1255-0.
[19] Gunn G B, Mendoza T R, Fuller C D, et al.High Symptom Burden Prior to Radiation Therapy for Head and Neck Cancer: A Patient-reported Outcomes Study[J]. Head Neck, 2013, 35(10):1490-1498. DOI:10.1002/Hed.23181.
[20] Chen A Y, Frankowski R, Bishop-Leone J, et al.The Development and Validation of a Dysphagia-specific Quality-of-life Questionnaire for Patients with Head and Neck Cancer:The M.D.Anderson Dysphagia Inventory[J]. Arch Otolaryngol Head Neck Surg, 2001,127(7):870-876.
[21] 邹敏,席淑新,吴沛霞,等. 中文版安德森吞咽困难量表的信效度研究[J]. 中华护理杂志, 2013, 48(11):1003-1007.DOI:10.3761/J.Issn.0254-1769.2013.11.013.
[22] Zhang L J, Jiang N, Li Z, et al.Psychometric Properties of the Chinese Version of the M.D.Anderson Dysphagia Inventory for Head and Neck Cancer Patients[J]. Cancer Nurs,2017,40(3):E9-E16.DOI:10.1097/NCC.0000000000000397.
[23] Hollander-Mieritz C, Johansen J, Johansen C, et al.Comparing the Patients’ Subjective Experiences of Acute Side Effects during Radiotherapy for Head and Neck Cancer with Four Different Patient-reported Outcomes Questionnaires[J]. Acta Oncol, 2019, 58(5):603-609. DOI:10.1080/0284186X.2018.1563713.
[24] Hanna E Y, Mendoza T R, Rosenthal D I, et al.The Symptom Burden of Treatment-naive Patients with Head and Neck Cancer[J]. Cancer, 2015, 121(5):766-773. DOI:10.1002/Cncr.29097.
[25] Chiang S H, Ho K Y, Wang S Y, et al.Change in Symptom Clusters in Head and Neck Cancer Patients Undergoing Postoperative Radiotherapy: A Longitudinal Study[J]. Eur J Oncol Nurs, 2018, 35:62-66. DOI:10.1016/J.Ejon.2018.01.014.
[26] Belqaid K, Orrevall Y, Mcgreevy J, et al.Self-reported Taste and Smell Alterations in Patients Under Investigation for Lung Cancer[J]. Acta Oncol, 2014, 53(10):1405-1412. DOI:10.3109/0284186X.2014.895035.
[27] Jin S, Lu Q, Jin S, et al.Relationship between Subjective Taste Alteration and Weight Loss in Head and Neck Cancer Patients Treated with Radiotherapy: A Longitudinal Study[J]. Eur J Oncol Nurs, 2018, 37:43-50. DOI:10.1016/J.Ejon.2018.10.003.
[28] Sozeri E, Kutluturkan S.The Validity and Reliability of Turkish Version of the Chemotherapy-induced Taste Alteration Scale (Citas)[J]. Clin Nurs Res, 2018, 27(2):235-249. DOI:10.1177/1054773816662436.
[29] Pang D, Qian L, Chen Z J, et al.Psychometric Properties of the Chinese Version of the Chemotherapy-induced Taste Alteration Scale[J]. Eur J Oncol Nurs, 2019,42:7-13. DOI:10.1016/J.Ejon.2019.07.007.
[30] Wu Y S, Lin P Y, Chien C Y, et al.Anxiety and Depression in Patients with Head and Neck Cancer: 6-Month Follow-up Study[J]. Neuropsychiatr Dis Treat, 2016, 12:1029-1036. DOI:10.2147/NDT.S103203.
[31] Rohde R L, Adjei Boakye E, Challapalli S D, et al.Prevalence and Sociodemographic Factors Associated with Depression among Hospitalized Patients with Head and Neck Cancer-results from a National Study[J]. Psychooncology, 2018, 27(12):2809-2814. DOI:10.1002/Pon.4893.
[32] Martin L, De Van Der Schueren M A E, Blauwhoff-Buskermolen S, et al. Identifying the Barriers and Enablers to Nutrition Care in Head and Neck and Esophageal Cancers[J]. JPEN, 2016, 40(3):355-366.DOI:10.1177/0148607114552847.
[33] Alberda C, Alvadj-Korenic T, Mayan M, et al.Nutrition Care in Patients with Head and Neck or Esophageal Cancer: The Patient Perspective[J]. Nutr Clin Pract,2017, 32(5):664-674.DOI:10.1177/0884533617725050.
[34] Britton B, Clover K, Bateman L, et al.Baseline Depression Predicts Malnutrition in Head and Neck Cancer Patients Undergoing Radiotherapy[J]. Support Care Cancer, 2012, 20(2):335-342.DOI:10.1007/S00520-011-1087-Y.
[35] Citak E, Tulek Z, Uzel O.Nutritional Status in Patients with Head and Neck Cancer Undergoing Radiotherapy: A Longitudinal Study[J]. Support Care Cancer, 2019, 27(1):239-247. DOI:10.1007/S00520-018-4319-6.
[36] Kubrak C, Olson K, Baracos V E.The Head and Neck Symptom Checklist©:An Instrument to Evaluate Nutrition Impact Symptoms Effect on Energy Intake and Weight Loss[J]. Support Care Cancer, 2013, 21(11):3127-3136. DOI:10.1007/S00520-013-1870-Z.
[37] Jin S, Lu Q, Pang D, et al.Validation of the Chinese Version of the Head and Neck Patient Symptom Checklist for Measuring Nutrition Impact Symptoms during Radiotherapy in Patients with Head and Neck Cancer[J]. Support Care Cancer, 2019, 27(12):4705-4711. DOI:10.1007/S00520-019-04784-3.
[38] Stover A, Irwin D E, Chen R C, et al.Integrating Patient-Reported Outcome Measures into Routine Cancer Care: Cancer Patients’ and Clinicians’ Perceptions of Acceptability and Value[J]. EGEMS (Wash DC), 2015, 3(1): 1169. DOI:10.13063/2327-9214.1169.
[39] Moon D H, Chera B S, Deal A M, et al.Clinician-observed and Patient-reported Toxicities and Their Association with Poor Tolerance to Therapy in Older Patients with Head and Neck or Lung Cancer Treated with Curative Radiotherapy[J]. J Geriatr Oncol, 2019,10(1):42-47.DOI:10.1016/J.Jgo.2018.05.016.
[40] Atkinson T M, Ryan S J, Bennett A V, et al.The Association between Clinician-based Common Terminology Criteria for Adverse Events (CTCAE) and Patient-reported Outcomes (PRO): A Systematic Review[J]. Support Care Cancer, 2016, 24(8):3669-3676. DOI:10.1007/S00520-016-3297-9.
[41] Basch E, Reeve B B, Mitchell S A, et al.Development of the National Cancer Institute’s Patient-reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)[J]. J Natl Cancer Inst, 2014, 106(9).DOI:10.1093/Jnci/Dju244.
[42] Van Der Wees P J, Nijhuis-Van Der Sanden M W, Ayanian J Z, et al. Integrating the Use of Patient-reported Outcomes for both Clinical Practice and Performance Measurement: Views of Experts From 3 Countries[J]. Milbank Q, 2014, 92(4):754-775. DOI:10.1111/1468-0009.12091.
[43] Bevans M, Ross A, Cella D.Patient-Reported Outcomes Measurement Information System (PROMIS): Efficient, Standardized Tools to Measure Self-reported Health and Quality of Life[J]. Nurs Outlook, 2014, 62(5):339-345. DOI:10.1016/j.outlook.2014.05.009.